Daclizumab and gastrointestinal haemorrhage Patient Reports February 12, 2012

Daclizumab Side Effects Report #5374245-0
Daclizumab side effect was reported by a Physician from SWEDEN on Mar 29, 2007. Male patient, 59 years of age, was treated with Daclizumab. After drug was administered, patient experienced the following side effects: gastrointestinal haemorrhage. Daclizumab dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, TACROLIMUS, METHYLPREDNISOLONE. Patient recovered.

Daclizumab Side Effects Report #4784748-5
Daclizumab side effect was reported by a Physician from CZECH REPUBLIC on Sept 20, 2005. Male patient, 55 years of age, weighting 169.8 lb, was treated with Daclizumab. After drug was administered, patient experienced the following side effects: gastric ulcer haemorrhage, gastrointestinal haemorrhage, immunosuppression, sepsis , shock haemorrhagic. Daclizumab dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, TACROLIMUS, CORTICOSTEROIDS, RANISAN, VENTER, ANOPYRIN. Patient was hospitalized. Patient recovered.

Daclizumab Side Effects Report #5320377-2
Daclizumab side effect was reported by a Physician from UNITED KINGDOM on May 02, 2007. Female patient, 44 years of age, was treated with Daclizumab. After drug was administered, patient experienced the following side effects: abdominal sepsis, ascites, atrial fibrillation , cellulitis , enterococcal infection, escherichia infection, gastrointestinal haemorrhage, haematoma, haemoglobin decreased. Daclizumab dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL. Patient was hospitalized and became disabled. Patient died on 06/14/2005.

Daclizumab Side Effects Report #4661735-9
Daclizumab side effect was reported by a Physician from on Apr 27, 2005. Female patient, 44 years of age, was treated with Daclizumab. After drug was administered, patient experienced the following side effects: ascites, blood albumin decreased, escherichia infection, gastrointestinal haemorrhage, laceration, oedema peripheral, pleural effusion, renal impairment, white blood cell count increased. Daclizumab dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL. Patient was hospitalized. Patient recovered.


Daclizumab Side Effects Report #4662520-4
Daclizumab side effect was reported by a Physician from on Apr 27, 2005. Female patient, 44 years of age, was treated with Daclizumab. After drug was administered, patient experienced the following side effects: ascites, blood albumin decreased, culture positive, escherichia infection, gastrointestinal haemorrhage, laceration, oedema peripheral, pleural effusion, renal impairment. Daclizumab dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL. Patient was hospitalized. Patient recovered.

Daclizumab Side Effects Report #4666052-9
Daclizumab side effect was reported by a Physician from on Apr 27, 2005. Female patient, 44 years of age, was treated with Daclizumab. After drug was administered, patient experienced the following side effects: ascites, escherichia infection, gastrointestinal haemorrhage, laceration, oedema peripheral, pleural effusion, renal impairment, small intestinal haemorrhage, white blood cell count increased. Daclizumab dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL. Patient was hospitalized. Patient recovered.

Daclizumab Side Effects Report #4674531-3
Daclizumab side effect was reported by a Physician from on Apr 27, 2005. Female patient, 44 years of age, was treated with Daclizumab. After drug was administered, patient experienced the following side effects: ascites infection, escherichia infection, gastrointestinal haemorrhage, haematemesis, haemoglobin decreased, pleural effusion, renal impairment, white blood cell count increased. Daclizumab dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL. Patient was hospitalized. Patient recovered.

Daclizumab Side Effects Report #4683900-7
Daclizumab side effect was reported by a Physician from on Apr 27, 2005. Female patient, 44 years of age, was treated with Daclizumab. After drug was administered, patient experienced the following side effects: ascites infection, blood albumin decreased, enterococcal infection, escherichia infection, gastrointestinal haemorrhage, haemoglobin decreased, laceration, oedema peripheral, pleural effusion. Daclizumab dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL. Patient was hospitalized. Patient recovered.

Daclizumab Side Effects Report #4700461-4
Daclizumab side effect was reported by a Physician from on Apr 27, 2005. Female patient, 44 years of age, was treated with Daclizumab. After drug was administered, patient experienced the following side effects: ascites infection, blood albumin decreased, blood culture positive, enterococcal infection, escherichia infection, gastrointestinal haemorrhage, haematemesis, haemoglobin decreased. Daclizumab dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL. Patient was hospitalized. Patient died on 06/14/2005.


Daclizumab Side Effects Report #4706625-8
Daclizumab side effect was reported by a Physician from UNITED KINGDOM on Apr 27, 2005. Female patient, 44 years of age, was treated with Daclizumab. After drug was administered, patient experienced the following side effects: abdominal sepsis, ascites infection, atrial fibrillation , blood albumin decreased, enterococcal infection, escherichia infection, gastrointestinal haemorrhage, haemoglobin decreased, multi-organ failure. Daclizumab dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL. Patient was hospitalized. Patient died on 06/14/2005.

Daclizumab Side Effects Report #4708358-0
Daclizumab side effect was reported by a Physician from UNITED KINGDOM on Apr 27, 2005. Female patient, 44 years of age, was treated with Daclizumab. After drug was administered, patient experienced the following side effects: abdominal sepsis, ascites infection, cellulitis , complications of transplanted liver, enterococcal infection, escherichia infection, gastrointestinal haemorrhage, multi-organ failure, pneumonia . Daclizumab dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL. Patient was hospitalized and became disabled. Patient died on 06/14/2005.

Daclizumab Side Effects Report #4709926-2
Daclizumab side effect was reported by a Physician from UNITED KINGDOM on Apr 27, 2005. Female patient, 44 years of age, was treated with Daclizumab. After drug was administered, patient experienced the following side effects: abdominal sepsis, ascites infection, atrial fibrillation , blood albumin decreased, cellulitis , diarrhoea, escherichia infection, gastrointestinal haemorrhage, haematemesis. Daclizumab dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL. Patient was hospitalized and became disabled. Patient died on 06/14/2005.